Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK

A population‐based epidemiological study of neuromyelitis optica spectrum disorder in Hungary

(2019) V. Papp et al.   EUROPEAN JOURNAL OF NEUROLOGY

Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008‒2018: A nationwide, population-based cohort study

(2019) Magnus S. Boesen et al.   Multiple Sclerosis and Related Disorders

Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark

(2018) Viktoria Papp et al.   NEUROLOGY

Incidence and prevalence of NMOSD in Australia and New Zealand

(2017) Wajih Bukhari et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates

(2017) Maria Sepúlveda et al.   Multiple Sclerosis Journal

Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates

(2017) Maria Sepúlveda et al.   Multiple Sclerosis Journal

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

(2015) Dean M. Wingerchuk et al.   NEUROLOGY

The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom

(2013) Anu Jacob et al.   JOURNAL OF NEUROLOGY

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan

(2012) Joanna Kitley et al.   BRAIN

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

(2012) J. Kitley et al.   NEUROLOGY

The prevalence of neuromyelitis optica in South East Wales

(2011) M. Cossburn et al.   EUROPEAN JOURNAL OF NEUROLOGY